Case report: apixaban-induced thrombocytopenia

Apixaban is a relatively new drug, and its safety profile is still being established. Thrombocytopenia is an uncommon, but life-threatening side effect with no previous published case repots. Clinicians must be aware of this and exercise caution particularly as some studies hint that it may be used in the management of HIT.